Try our new Velocity vials
By apsulis
SGD Pharma has launched a new range of innovative Type I tubular vials for injectable…
Have you heard about our new siliconization operation?
By apsulis
We are pleased to announce the opening of a siliconization line at our state-of-the-art Saint-Quentin…
SGD Pharma expands capacity of siliconized glass vials with the announcement of a new siliconization line at its Center of Excellence for Type I glass in France
By apsulis
SGD Pharma, Global market leader in molded glass primary packaging solutions for the pharmaceutical industry,…
SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit
By apsulis
The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and…
SGD Pharma celebrates the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2
By apsulis
SGD Pharma marked the start of the New Year by celebrating the renovation of its…
SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements
By apsulis
SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass…
Navigating Sustainability Challenges in the Pharmaceutical Industry: Insights on Glass Packaging and Regulatory Changes
By apsulis
In a recent roundtable hosted by Pharma’s Almanac, Olivier Rousseau, the Chief Executive Officer of…
SGD Pharma’s Commitment to Fighting Global Warming and Biodiversity Conservation: A Journey with the Zhanjiang Mangrove Wetland Conservation Federation
By apsulis
SGD Pharma is committed to fight global warming. Our decarbonization strategy and our goal to…
PDA Packaging Conference | 23 TO 24 APRIL – Copenhagen, Denmark
By apsulis
Home Archives for apsulis Page 10 5 DECEMBER 2023 PDA Packaging Conference | 23 TO…